53 phenotypes from 8 alleles in 10 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
RictorGt(RRR347)Byg/RictorGt(RRR347)Byg involves: 129P2/OlaHsd	abnormal placenta morphology	J:137592
	embryonic growth retardation	J:137592
	embryonic lethality during organogenesis, complete penetrance	J:137592
	thick placenta labyrinth	J:137592
RictorGt(RRR347)Byg/RictorGt(RRR347)Byg involves: 129P2/OlaHsd * C57BL/6J	embryonic lethality during organogenesis, complete penetrance	J:113443
Rictortm1.1Klg/Rictortm1.1Klg Tg(Mx1-cre)1Cgn/0 B6.Cg-Rictortm1.1Klg Tg(Mx1-cre)1Cgn	abnormal double-negative T cell morphology	J:189736
	decreased DN1 thymic pro-T cell number	J:189736
	decreased DN2 thymocyte number	J:189736
	decreased DN3 thymocyte number	J:189736
	decreased DN4 thymocyte number	J:189736
	decreased double-positive T cell number	J:189736
	decreased single-positive T cell number	J:189736
	decreased T cell proliferation	J:189736
	decreased thymus weight	J:189736
	normal hematopoietic system phenotype	J:189736
	normal immune system phenotype	J:189736
	increased double-negative T cell number	J:189736
	thymus hypoplasia	J:189736
Rictortm1.1Mgn/Rictortm1.1Mgn Tg(Ins2-cre)25Mgn/0 involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA	abnormal glucose homeostasis	J:170129
	abnormal pancreatic beta cell physiology	J:170129
	decreased insulin secretion	J:170129
	decreased pancreatic beta cell mass	J:170129
	decreased pancreatic beta cell proliferation	J:170129
	hyperglycemia	J:170129
	impaired glucose tolerance	J:170129
Rictortm1.1Mgn/Rictortm1.2Mgn Meox2tm1(cre)Sor/Meox2+ involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * FVB/N * SJL	lethality throughout fetal growth and development, incomplete penetrance	J:119564
Rictortm1.1Mnh/Rictortm1.1Mnh Tg(Fabp4-cre)1Rev/0 B6.Cg-Rictortm1.1Mnh Tg(Fabp4-cre)1Rev	decreased adiponectin level	J:150064
	enlarged pancreatic islets	J:150064
	improved glucose tolerance	J:150064
	increased body length	J:150064
	increased bone mineral content	J:150064
	increased circulating cholesterol level	J:150064
	increased circulating insulin level	J:150064
	increased circulating insulin-like growth factor I level	J:150064
	increased epididymal fat pad weight	J:150064
	increased heart weight	J:150064
	increased kidney weight	J:150064
	increased lean body mass	J:150064
	increased liver weight	J:150064
	increased pancreas weight	J:150064
	increased spleen weight	J:150064
	increased susceptibility to weight gain	J:150064
	insulin resistance	J:150064
	macrovesicular hepatic steatosis	J:150064
Rictortm1.2Mgn/Rictortm1.2Mgn involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL	abnormal placenta labyrinth morphology	J:119564
	abnormal placental labyrinth vasculature morphology	J:119564
	decreased cell proliferation	J:119564
	decreased embryo size	J:119564
	embryonic lethality during organogenesis, complete penetrance	J:119564
Rictortm1.2Mgn/Rictortm1.3Mgn involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL	abnormal placenta labyrinth morphology	J:119564
	abnormal placental labyrinth vasculature morphology	J:119564
	decreased embryo size	J:119564
	embryonic lethality during organogenesis, complete penetrance	J:119564
Rictortm1.3Mgn/Rictortm1.3Mgn involves: 129S6/SvEvTac * C57BL/6 * FVB/N	abnormal placenta labyrinth morphology	J:119564
	abnormal placental labyrinth vasculature morphology	J:119564
	decreased embryo size	J:119564
	embryonic lethality during organogenesis, complete penetrance	J:119564
Rictortm1Mgn/Rictortm1Mgn involves: 129S6/SvEvTac * C57BL/6	abnormal placenta labyrinth morphology	J:119564
	hydrops fetalis	J:119564
	lethality throughout fetal growth and development, complete penetrance	J:119564
	small placenta	J:119564
Rictortm1Rueg/Rictortm1Rueg Tg(ACTA1-cre)1Mll/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL	increased body weight	J:143748
	normal mortality/aging	J:143748
	normal muscle phenotype	J:143748